Covered recipient · General Payments record
SARAH J ALLEY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$6,091.03
- Reported across 411 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $649.33 | 33 |
| Education | $32.27 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $224.73 | 14 |
| Astellas Pharma US Inc | $138.35 | 2 |
| Novo Nordisk AS | $95.63 | 5 |
| PFIZER INC. | $86.85 | 5 |
| Bayer HealthCare Pharmaceuticals Inc. | $31.14 | 2 |
| Xeris Pharmaceuticals, Inc. | $22.45 | 1 |
| Phathom Pharmaceuticals, Inc. | $20.60 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.24 | 1 |
| GlaxoSmithKline, LLC. | $14.73 | 1 |
| Abbott Laboratories | $14.19 | 1 |
| Acerta Pharma LLC | $13.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.19 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125331612 | CMS |
| ABBVIE INC. | $18.25 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209013 | CMS |
| ABBVIE INC. | $21.81 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209015 | CMS |
| ABBVIE INC. | $14.35 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209017 | CMS |
| ABBVIE INC. | $21.75 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209019 | CMS |
| ABBVIE INC. | $23.81 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209021 | CMS |
| ABBVIE INC. | $10.49 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209023 | CMS |
| ABBVIE INC. | $12.08 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209025 | CMS |
| ABBVIE INC. | $16.44 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209027 | CMS |
| ABBVIE INC. | $17.10 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209029 | CMS |
| ABBVIE INC. | $26.53 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209031 | CMS |
| ABBVIE INC. | $11.67 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209033 | CMS |
| ABBVIE INC. | $9.16 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209035 | CMS |
| ABBVIE INC. | $3.43 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209037 | CMS |
| ABBVIE INC. | $17.86 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209039 | CMS |
| Astellas Pharma US Inc | $16.95 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139301534 | CMS |
| Astellas Pharma US Inc | $121.40 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139379632 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.69 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104412791 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.74 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086168250 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.40 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086232620 | CMS |
| GlaxoSmithKline, LLC. | $14.73 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115832131 | CMS |
| Novo Nordisk Inc | $18.60 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097676199 | CMS |
| Novo Nordisk Inc | $16.48 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096818383 | CMS |
| Novo Nordisk Inc | $32.27 | 04/16/2024 | Education | Undisputed | 01/23/2026 | 1096837608 | CMS |
| Novo Nordisk Inc | $14.01 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097713570 | CMS |
| Novo Nordisk Inc | $14.27 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097828067 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.24 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118851488 | CMS |
| PFIZER INC. | $17.71 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132032046 | CMS |
| PFIZER INC. | $20.02 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132032048 | CMS |
| PFIZER INC. | $17.72 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131667365 | CMS |
| PFIZER INC. | $16.11 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131741644 | CMS |
| PFIZER INC. | $15.29 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131744546 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.60 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151034302 | CMS |
| Xeris Pharmaceuticals, Inc. | $22.45 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144612596 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.